2019
DOI: 10.3389/fneur.2019.00773
|View full text |Cite
|
Sign up to set email alerts
|

Post-polio Syndrome: More Than Just a Lower Motor Neuron Disease

Abstract: Post-polio syndrome (PPS) is a neurological condition that affects polio survivors decades after their initial infection. Despite its high prevalence, the etiology of PPS remains elusive, mechanisms of progression are poorly understood, and the condition is notoriously under-researched. While motor dysfunction is a hallmark feature of the condition, generalized fatigue, sleep disturbance, decreased endurance, neuropsychological deficits, sensory symptoms, and chronic pain are also often reported and have consi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
39
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 66 publications
(40 citation statements)
references
References 191 publications
1
39
0
Order By: Relevance
“…Being aware of getting pain after physical activity also meant that they avoided activities in general. Pain has previously been reported to be common among people with LEoP affecting physical and psychological functioning (15,18,20,27), which was in line with the findings in our study.…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…Being aware of getting pain after physical activity also meant that they avoided activities in general. Pain has previously been reported to be common among people with LEoP affecting physical and psychological functioning (15,18,20,27), which was in line with the findings in our study.…”
Section: Discussionsupporting
confidence: 93%
“…Impairments that the participants were least bothered by were breathing difficulties at rest, concentration and memory difficulties, which are impairments that are commonly reported and indirectly associated with LEoP (8). Deductive analysis showed that general fatigue [38], muscle weakness [32] and muscle fatigue [27] had the highest representation with regard to the number of statements [in brackets]. The participants described that increased general fatigue, muscle weakness and muscle fatigue contributed to making daily life more difficult; for example, carrying out daily chores and limited their participation in social activities.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In clinical practice however, the main differential diagnosis of KD is ALS, which can be readily distinguished from KD due to the more rapid functional decline, the presence of upper motor neuron signs, the absence of sensory neuropathy and endocrine disorders (Table 2). Less likely differential diagnoses include conditions with lower motor neuron presentations, such as Hirayama disease [124], multifocal motor neuropathy, spinal muscular atrophy (SMA) [125], post-polio syndrome (PPS) [126], CIDP, progressive bulbar palsy (PBP) [41], progressive muscular atrophy (PMA), spinal cord ischaemia [92], myelopathies [127] and Charcot-Marie-Tooth disease, but most of these conditions have specific radiological, molecular or electrophysiological features which help to distinguish them from KD. The other differential diagnoses depend on the initial constellation of clinical signs or symptoms which are often extra-neurological (Table 3).…”
Section: Differential Diagnosismentioning
confidence: 99%
“…While the methodological focus of the papers differs depending the expertise profile of the authors, there is a cohesive theme among the papers to appraise biological, molecular, electrophysiological, and radiological markers which may potentially serve as pragmatic clinical indicators confirming the diagnosis, predicting the prognosis, detecting response to therapy or track longitudinal neurodegenerative changes. Beyond the practical relevance of ascertaining and quantifying pathological changes in vivo, biomarkers in MND also provide considerable academic insights such as the exploration of presymptomatic changes (23,24), the description of genotype-associated signatures (25,26), the delineation of natural disease trajectories (11,27), the characterization of low-incidence phenotypes (2,28,29), confirmation of epigenetic and epidemiological factors (30,31), and deciphering the pathological substrate of clinical symptoms [Finegan et al; (32,33)].…”
Section: Introductionmentioning
confidence: 99%